Blood samples from 80 shelter cats in São Luís, Brazil, were examined in the laboratory. Four tested positive for FeLV, and both FeLV-A and FeLV-B were detected in all four. The study did not demonstrate that the viruses in these samples caused lymphoma or leukemia. The authors acknowledge that some latent bone-marrow infections might have gone undetected, without demonstrating that this happened, and the paper contains inconsistencies that limit its interpretation.
The study published in Virus genes in 2023 (doi: 10.1007/s11262-023-01997-x), classified in the knowledge object as in vitro, characterized samples from naturally infected cats. Blood was collected from 80 shelter cats in São Luís, Maranhão, Brazil, and four samples were reported as FeLV-positive, with co-detection of FeLV-A and FeLV-B. The description of the sampled population has evidence level C; it does not describe a cancer cohort or provide a representative population-wide estimate. The gag phylogenetic analysis included the four São Luís samples and 46 GenBank reference sequences.
The Discussion associates FeLV-B with lymphomas and describes its origin through recombination between FeLV-A and endogenous retroviral sequences. This mechanistic account is literature-based and has evidence level D within this paper: the support is indirect, rather than extrapolated from another species. A recombination event was not experimentally demonstrated in the four samples. The oncology relevance is contextual: no tumor-defined comparison group or longitudinal cancer outcomes were reported. Nor were the sampled strains shown to cause lymphoma or leukemia; gag phylogenetic differentiation does not establish altered oncogenic potential.
The authors acknowledge that hypothetical latent bone-marrow infections might have escaped serology and whole-blood PCR. This statement, with evidence level C, documents an acknowledged ascertainment limitation, not demonstrated missed infections. Subtype T was not tested. The effects of recombinant sequences on transmission remain unknown, as do the enFeLV loci that are active and associated with recombinant-virus generation. The study does not map those active loci or establish their contribution to oncogenesis.
The Results also report subtype frequencies with a denominator of 53 whose relationship to the study sample is unexplained. They describe two clades but list three. These reporting inconsistencies, together with the characterization of only four positive samples, limit interpretation.
There is direct molecular evidence of FeLV-A and FeLV-B co-detection in four positive samples from 80 shelter cats sampled. The paper acknowledges the possibility that serology and whole-blood PCR could have missed hypothetical latent bone-marrow infections. The account of FeLV-B's recombinant origin comes from the literature discussed, not from an experimental demonstration in these samples.
Whether latent infections actually went undetected is unknown; subtype T was not tested. The sampled strains were not established to cause lymphoma or leukemia, nor was their phylogenetic differentiation shown to imply altered oncogenic potential. The effects of recombinant sequences on transmission and the identity of active enFeLV loci associated with recombinant-virus generation remain open questions; their contribution to oncogenesis was not established either. The denominator of 53 and the discrepancy in the number of clades remain unexplained.
Excerpt verified in the source — verbatim, in the source's own language“Hypothetically, some animals may have had latent infections in the bone marrow and were not diagnosed by serology and total blood PCR (leukocyte layer).”
This is evidence of an explicitly acknowledged ascertainment limitation, not evidence that missed latent infections actually occurred.
Excerpt verified in the source — verbatim, in the source's own language“Blood samples were collected from eighty cats from shelters in the city of São Luís, Maranhão, Brazil.”
This defines the sampling population, not a cancer cohort or a representative population-wide estimate. Only four samples were subsequently reported as FeLV-positive.
Excerpt verified in the source — verbatim, in the source's own language“FeLV-B is generated from recombination between FeLV-A and the endogenous retroviral sequences [ 3 , 46 ].”
This is a literature-based mechanistic statement, not a recombination event experimentally demonstrated in the four São Luís samples. Level D reflects indirect support within this paper rather than a non-feline application.
The Discussion explicitly identifies this uncertainty. The study does not map active endogenous loci or establish their contribution to oncogenesis.
AVA